Pharma - Industry – Focus

 

Custom Search

Novo Norsdik plans Tresiba- a insulin degludec in India

Novo Norsdik, a Denmark based global healthcare organization is based in India. The company plans to launch 'Tresiba' a long lasting insulin injection in India. The drug used for Type I and Type II diabetes is likely to be available by end of 2013. It is once-daily injection and will be long acting till 42 hours, thereby providing patients enough time to manage the disease. Tresiba will be available in pre-filled pen enabling does upto 80 units in a single injection.

Custom Search

Copyright © 2013 Ibis Research Information Services Pvt Ltd. All Rights Reserved.
Contact : Ibis Research Information Services Pvt Ltd., 28, Rajaji Street, NGO Colony
Guduvancherry, Chennai -603 202   Mobile : 0-97898-37940 email : ibischennai@gmail.com Privacy Policy